INS and diabetes mellitus: Several multistep protocols have been described [6, 17, 26–33] to differentiate human embryonic or inducible pluripotent stem cells into pancreatic progenitors able to undergo in vivo maturation with generation of glucose sensitive insulin secreting cells able to reverse diabetes in mice [17, 28, 34].